Biosynex SA (FR:ALBIO) has released an update. Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test ...

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA, a leader in health diagnostics, reported a turnover of €93 million in 2023 and has expanded its international presence with subsidiaries in ...

STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and ...

A financially strapped Hauppauge-based manufacturer of diagnostic tests is being purchased by a French test maker for $17.2 million in cash, officials said. Chembio Diagnostics Inc. has signed a ...

The deadline for shareholders of Chembio Diagnostics Inc. to agree to its proposed merger with a French company has been extended for a third time, officials said. The new deadline of 6 p.m. on April ...

Feb 16 (Reuters) - Biosynex SA : * Obtains CE mark for rapid serological test new generation of infection by HIV 1 and 2 responsible for AIDS (Exacto Pro Test HIV) Source text: bit.ly/215UZVd Further ...